Collaborations

Illumina, Mayo collaborate to develop molecular diagnostics for complex diseases

Published in Health Business Week, February 16th, 2007

Illumina, Inc., (ILMN) and Mayo Clinic announced that they have signed a diagnostic collaborative agreement to enable the codevelopment of molecular diagnostic tests for the study of complex diseases.

The agreement recognizes the strengths of both organizations. Illumina will contribute its VeraCode technology and development expertise for the BeadArray and BeadXpress instrument platforms. Mayo Clinic will bring broad knowledge in clinical practice and patient outcome management along with proficiency in establishing clinical utility of new diagnostic technologies. In addition, Mayo’s ability to discover and validate biomarkers offers the potential for both parties to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2007-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry